P.2.080 Risperidone in the treatment of acute bipolar mania: A double-blind, placebo-controlled study of 290 patients

S. Khanna; Eduard Vieta; Benjamin Lyons; F. Grossman; M.R. Kramer

doi:10.1016/s0924-977x(03)92033-5

Related publications

Article2017

A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study)

Ulrich Hegerl, Roland Mergl, Christian Sander, Jens Dietzel, István Bitter, Koen Demyttenaere, Ricardo Gusmão, Ana González‐Pinto, Eric P. Zorrilla, Adriana García Alocén, Víctor Pérez, Eduard Vieta, Georg Juckel, U. Zimmermann, Michael Bauer, Pascal Sienaert, Sónia Quintão, Marc‐Andreas Edel, Csilla Bolyós, José Luís Ayuso‐Mateos, Pilar López-García, Michael Kluge

Article2013

Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate

Michael Kluge, Ulrich Hegerl, Christian Sander, Jens Dietzel, Roland Mergl, István Bitter, Koen Demyttenaere, Ricardo Gusmão, Ana González‐Pinto, Víctor Pérez, Eduard Vieta, Georg Juckel, U. Zimmermann, Michael Bauer, Pascal Sienaert, Sónia Quintão, Marc‐Andreas Edel, Csilla Bolyós, José Luís Ayuso‐Mateos, Pilar López-García

Article2021

Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania

Eduard Vieta, Gary Sachs, Denise Chang, Johan Hellsten, Claudette Brewer, Timothy Peters-Strickland, Nanco Hefting

Article2003

Mood stabilisers plus risperidone or placebo in the treatment of acute mania

Lakshmi N. Yatham, Fred Grossman, Ilse Augustyns, Eduard Vieta, Arun Ravindran

Article2010

P03-359 Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Long-Acting Injectable in Relapse Prevention in Patients with Bipolar I Disorder

Stuart Montgomery, Eduard Vieta, Ahmad Hatim Sulaiman, Rodrigo Córdoba, Benedicte Huberlant, A. Schreiner, G. Martinez